Novel epitranscriptomic and epigenetic therapeutic strategies and targets for ferroptosis in liver fibrosis
- 25 February 2025
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 996, 177344
Abstract
No abstract availableKeywords
Funding Information
- Anhui Medical University (2019GMFY07)
- University Natural Science Research Project of Anhui Province (2024AH050803)
- National Natural Science Foundation of China (81600477)
- Natural Science Research Project of Guizhou Province (KJ2020A0181, 2208085MH215, 2408085MH213)
This publication has 179 references indexed in Scilit:
- Epitranscriptomic regulation of lipid oxidation and liver fibrosis via ENPP1 mRNA m6A modificationCellular and Molecular Life Sciences, 2024
- Ferroptosis in Osteocytes as a Target for Protection Against Postmenopausal OsteoporosisAdvanced Science, 2024
- The epigenetic regulatory mechanisms of ferroptosis and its implications for biological processes and diseasesMedcomm, 2023
- Ferroptosis in cancer and cancer immunotherapyCancer Communications, 2022
- CircKDM4C upregulates P53 by sponging hsa‐let‐7b‐5p to induce ferroptosis in acute myeloid leukemiaEnvironmental Toxicology, 2021
- DNA Methylation Profiling of Human HepatocarcinogenesisHepatology, 2020
- Consensus mutagenesis approach improves the thermal stability of system xc− transporter, xCT, and enables cryo‐EM analysesProtein Science, 2020
- CircIL4R facilitates the tumorigenesis and inhibits ferroptosis in hepatocellular carcinoma by regulating the miR‐541‐3p/GPX4 axisCell Biology International, 2020
- Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatinJournal of Cellular Physiology, 2019
- Histones and heart failure in diabetesCellular and Molecular Life Sciences, 2018